<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04197583</url>
  </required_header>
  <id_info>
    <org_study_id>U0652</org_study_id>
    <nct_id>NCT04197583</nct_id>
  </id_info>
  <brief_title>DJUS Postmarket Registry</brief_title>
  <official_title>Boston Scientific Double-J Ureteral Stent Postmarket Patient Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center global registry to obtain post-market safety and efficacy data on Boston
      Scientific Double-J Ureteral Stents
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 19, 2020</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>15 Months</target_duration>
  <primary_outcome>
    <measure>Technical Success</measure>
    <time_frame>2 months to 12 Months</time_frame>
    <description>Stented kidney drains (to bladder) during the planned indwell time with no re-intervention due to obstruction of the stented ureters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary safety endpoint</measure>
    <time_frame>2 months to 12 Months</time_frame>
    <description>Any Serious Adverse Device Effects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life - Patient-Reported Outcomes</measure>
    <time_frame>2 months, 12 Months</time_frame>
    <description>Measurement System (PROMIS®) for subjects ≥18 years
PROMIS Adult Short Form v1.0 - Pain Intensity 3a
PROMIS Adult Short Form v1.0 - Pain Interference 6b</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Migration</measure>
    <time_frame>2 months to 12 Months</time_frame>
    <description>Stent Migration: Confirmed via imaging</description>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Ureter Obstruction</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Double-J Ureteral Stent</intervention_name>
    <description>A BSC Double-J Ureteral Stent is an implantable device that is used to restore flow of urine from the kidney to the bladder in obstructed ureters.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study will enroll patients who has ureteral obstruction and are receiving Double-J Ureteral
        stent as part of their standard of care
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is undergoing placement of a Boston Scientific Double-J Ureteral Stent

          -  Subject anatomy is appropriate to accommodate a stent size available in the study

          -  Subject is able to accurately detect and report bladder function and pain

          -  Subject is willing and able to:

        Complete patient QoL questionnaire at specified time points (for subjects aged ≥ 18 years)
        Return for all follow-up visits

        Exclusion Criteria:

          -  Subjects who meet any of the contraindications per individual stent DFU

          -  Subjects receiving different stent type in case of bilateral/multiple stenting

          -  Subjects with an indwelling ureteral stent(s) not planned to be removed prior to/or
             concurrently with the study stent implant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clinical Project Manager</last_name>
    <phone>351-208-3684</phone>
    <email>URODJUS@bsci.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Indiana University Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christa Stoughton</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HealthEast Medical Research Institute</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Savannah Novy</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 11, 2019</study_first_submitted>
  <study_first_submitted_qc>December 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>April 8, 2020</last_update_submitted>
  <last_update_submitted_qc>April 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ureteral Obstruction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

